137 related articles for article (PubMed ID: 14607620)
1. Recurrence and metastasis of hepatocellular carcinoma: progress and prospects.
Zhou XD
Hepatobiliary Pancreat Dis Int; 2002 Feb; 1(1):35-41. PubMed ID: 14607620
[TBL] [Abstract][Full Text] [Related]
2. Surgical treatment of hepatocellular carcinoma and related basic research with special reference to recurrence and metastasis.
Tang Z; Zhou X; Lin Z; Yang B; Ma Z; Ye S; Wu Z; Fan J; Liu Y; Liu K; Qin L; Tian J; Sun H; He B; Xia J; Qiu S; Zhou J
Chin Med J (Engl); 1999 Oct; 112(10):887-91. PubMed ID: 11717970
[TBL] [Abstract][Full Text] [Related]
3. Alterations of oncogenes, tumor suppressor genes and growth factors in hepatocellular carcinoma: with relation to tumor size and invasiveness.
Tang Z; Qin L; Wang X; Zhou G; Liao Y; Weng Y; Jiang X; Lin Z; Liu K; Ye S
Chin Med J (Engl); 1998 Apr; 111(4):313-8. PubMed ID: 10374394
[TBL] [Abstract][Full Text] [Related]
4. Three decades' experience in surgery of hepatocellular carcinoma.
Tang ZY; Yu YQ; Zhou XD; Yang BH; Lin ZY; Lu JZ; Ma ZC; Ye SL; Liu KD
Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():126-33. PubMed ID: 9210895
[TBL] [Abstract][Full Text] [Related]
5. [Association of VEGF, uPA, ICAM-1 and PCNA expression with metastasis and recurrence in hepato cellular carcinoma].
Meng C; Chen X
Zhonghua Wai Ke Za Zhi; 2002 Sep; 40(9):673-5. PubMed ID: 12411137
[TBL] [Abstract][Full Text] [Related]
6. Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.
Shah SA; Cleary SP; Wei AC; Yang I; Taylor BR; Hemming AW; Langer B; Grant DR; Greig PD; Gallinger S
Surgery; 2007 Mar; 141(3):330-9. PubMed ID: 17349844
[TBL] [Abstract][Full Text] [Related]
7. Progress and prospects in hepatocellular carcinoma surgery.
Tang ZY; Yu YQ; Zhou XD; Ma ZC; Wu ZQ
Ann Chir; 1998; 52(6):558-63. PubMed ID: 9752506
[TBL] [Abstract][Full Text] [Related]
8. [Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma].
Moon JI; Kim JM; Jung GO; Chun JM; Choi GS; Park JB; Kwon CH; Kim SJ; Jo JW
Korean J Hepatol; 2008 Jun; 14(2):185-96. PubMed ID: 18617766
[TBL] [Abstract][Full Text] [Related]
9. Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness.
Sergio A; Cristofori C; Cardin R; Pivetta G; Ragazzi R; Baldan A; Girardi L; Cillo U; Burra P; Giacomin A; Farinati F
Am J Gastroenterol; 2008 Apr; 103(4):914-21. PubMed ID: 18177453
[TBL] [Abstract][Full Text] [Related]
10. Prognosis of patients with intrahepatic recurrence after hepatic resection for hepatocellular carcinoma: a retrospective study.
Kawano Y; Sasaki A; Kai S; Endo Y; Iwaki K; Uchida H; Shibata K; Ohta M; Kitano S
Eur J Surg Oncol; 2009 Feb; 35(2):174-9. PubMed ID: 18325724
[TBL] [Abstract][Full Text] [Related]
11. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma.
Tung-Ping Poon R; Fan ST; Wong J
Ann Surg; 2000 Jul; 232(1):10-24. PubMed ID: 10862190
[TBL] [Abstract][Full Text] [Related]
12. Posthepatectomy HBV reactivation in hepatitis B-related hepatocellular carcinoma influences postoperative survival in patients with preoperative low HBV-DNA levels.
Huang G; Lai EC; Lau WY; Zhou WP; Shen F; Pan ZY; Fu SY; Wu MC
Ann Surg; 2013 Mar; 257(3):490-505. PubMed ID: 22868358
[TBL] [Abstract][Full Text] [Related]
13. Solitary large hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection.
Yang LY; Fang F; Ou DP; Wu W; Zeng ZJ; Wu F
Ann Surg; 2009 Jan; 249(1):118-23. PubMed ID: 19106686
[TBL] [Abstract][Full Text] [Related]
14. Portal venous invasion: the single most independent risk factor for immediate postoperative recurrence of hepatocellular carcinoma.
Choi KK; Kim SH; Choi SB; Lim JH; Choi GH; Choi JS; Kim KS
J Gastroenterol Hepatol; 2011 Nov; 26(11):1646-51. PubMed ID: 21592228
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological risk factors linked to recurrence pattern after curative hepatic resection for hepatocellular carcinoma--results of 152 resected cases.
Shirabe K; Wakiyama S; Gion T; Motomura K; Koyanagi T; Sakamoto S; Nagaie T
Hepatogastroenterology; 2007; 54(79):2084-7. PubMed ID: 18251164
[TBL] [Abstract][Full Text] [Related]
16. Serum and tissue vascular endothelial growth factor predicts prognosis in hepatocellular carcinoma patients after partial liver resection.
Zhong C; Wei W; Su XK; Li HD; Xu FB; Guo RP
Hepatogastroenterology; 2012; 59(113):93-7. PubMed ID: 22251524
[TBL] [Abstract][Full Text] [Related]
17. Expression of vascular endothelial growth factor and matrix metalloproteinase-2 correlates with the invasion and metastasis of hepatocellular carcinoma.
Liu Z; Yan L; Xiang T; Jiang L; Yang B
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Jun; 20(2):249-50, 254. PubMed ID: 12856590
[TBL] [Abstract][Full Text] [Related]
18. [Appraisal of postoperative transcatheter arterial chemoembolization (TACE) for prevention and treatment of hepatocellular carcinoma recurrence].
Lin Z; Ren Z; Xia J
Zhonghua Zhong Liu Za Zhi; 2000 Jul; 22(4):315-7. PubMed ID: 11778559
[TBL] [Abstract][Full Text] [Related]
19. Re-evaluation of lipiodolized transarterial chemoembolization therapy for intrahepatic recurrence of hepatocellular carcinoma after curative liver resection.
Eguchi S; Matsumoto S; Hamasaki K; Takatsuki M; Hidaka M; Tajima Y; Sakamoto I; Kanematsu T
J Hepatobiliary Pancreat Surg; 2008; 15(6):627-33. PubMed ID: 18987934
[TBL] [Abstract][Full Text] [Related]
20. [Relationship between serum matrix metalloproteinase-2 and metastasis and recurrence following radical hepatic resection in hepatocellular carcinoma].
Niu Q; Tang Z; Ma Z; Qin L; Bao W; Zhang L
Zhonghua Gan Zang Bing Za Zhi; 2001 Jul; 9 Suppl():58-60. PubMed ID: 11509142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]